← All compounds

Metabolic & endocrine

Retatrutide

Triple GIP, GLP-1 and glucagon receptor agonist

COMPOUND GUIDE20 mg$120 CAD

Price per bottle · Shipping charged separately.

COMPOUND OVERVIEW

What's In It

Retatrutide (LY3437943 sequence)

A synthetic 39-amino-acid triple-agonist peptide engineered to bind GIP, GLP-1, and glucagon receptors, supplied strictly as an unapproved investigational laboratory reference material. Not a medicine and not for human or veterinary use.

Areas of Research Interest
  • GLP-1/GIP/glucagon receptor research
  • GLP-1 receptor binding assays
  • GIP receptor signaling
  • Glucagon receptor kinetics
  • Incretin pathway cross-talk
  • Hepatic lipid-pathway models

Investigational / Restricted Reference Notice: This compound corresponds to an investigational or prescription-class molecular target in certain jurisdictions. Offered exclusively as an unapproved laboratory reference material for qualified bench research. Not authorized by Health Canada and strictly not for human or veterinary use.

Availability & pricing

Contact Onyx Peptides to confirm laboratory availability, pricing, or lot COAs. 18+ and research-use confirmation required before WhatsApp inquiry.

Message on WhatsApp
peptides@onyxpeptide.ca

Compound Profile

Retatrutide compound profile